Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
It’s been almost a month since the new FTC rule was officially approved, but if you still can’t smell what The Rock-a-Khan is ...
The Washington Post on MSN1d
FTC sues pharmacy insurance managers, alleging unfair drug pricesThe Federal Trade Commission sued the three dominant pharmacy-benefit managers ... of a product that is essential for people with diabetes. According to the FTC, the three largest PBMs — CVS ...
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback